In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...

Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...

Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...

Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...

Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...

Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

Thomas is best known as the host of the fitness-makeover series Operation Transformation, which was cancelled in early 2024 ...

A receding hairline may be common — about two-thirds of men start losing their hair by age 35 — but that doesn’t make it any ...

The Irish Pharmaceutical Healthcare Association has said that patients in Ireland could get access to new medicines a year earlier, if there were reforms here.

It currently takes over twenty months on average for the HSE to make a new a medicine available to a patient under one of its drugs schemes, a conference will be told today.